Supernus Pharmaceuticals (SUPN) Shares Outstanding (Entity) (2011 - 2026)
Supernus Pharmaceuticals (SUPN) Shares Outstanding (Entity) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 834.66 Mn |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | 58.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.16 Mn |
| Mar 31, 2026 | 58.04 Mn |
| Dec 31, 2025 | 57.46 Mn |
| Sep 30, 2025 | 57.12 Mn |
| Jun 30, 2025 | 56.12 Mn |
| Mar 31, 2025 | 55.99 Mn |
| Dec 31, 2024 | 55.74 Mn |
| Sep 30, 2024 | 55.22 Mn |
| Jun 30, 2024 | 55.05 Mn |
| Mar 31, 2024 | 54.97 Mn |
| Dec 31, 2023 | 54.97 Mn |
| Sep 30, 2023 | 54.63 Mn |
| Jun 30, 2023 | 54.59 Mn |
| Mar 31, 2023 | 54.47 Mn |
| Dec 31, 2022 | 54.47 Mn |
| Sep 30, 2022 | 54.05 Mn |
| Jun 30, 2022 | 53.49 Mn |
| Mar 31, 2022 | 53.39 Mn |
| Dec 31, 2021 | 53.26 Mn |
| Sep 30, 2021 | 53.18 Mn |